Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Debt Ratio (2020 - 2023)

Historic Debt Ratio for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Q1 2023 value amounting to 0.0.

  • Mirum Pharmaceuticals' Debt Ratio fell 5445.85% to 0.0 in Q1 2023 from the same period last year, while for Mar 2023 it was 0.0, marking a year-over-year decrease of 5445.85%. This contributed to the annual value of 0.0 for FY2022, which is 5440.53% down from last year.
  • Mirum Pharmaceuticals' Debt Ratio amounted to 0.0 in Q1 2023, which was down 5445.85% from 0.0 recorded in Q4 2022.
  • Mirum Pharmaceuticals' Debt Ratio's 5-year high stood at 0.01 during Q2 2021, with a 5-year trough of 0.0 in Q4 2022.
  • Moreover, its 4-year median value for Debt Ratio was 0.01 (2020), whereas its average is 0.01.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Debt Ratio soared by 7148.49% in 2022, and later tumbled by 5445.85% in 2023.
  • Over the past 4 years, Mirum Pharmaceuticals' Debt Ratio (Quarter) stood at 0.01 in 2020, then rose by 29.09% to 0.01 in 2021, then plummeted by 54.41% to 0.0 in 2022, then increased by 5.81% to 0.0 in 2023.
  • Its Debt Ratio was 0.0 in Q1 2023, compared to 0.0 in Q4 2022 and 0.0 in Q3 2022.